by Sam Minton | Oct 18, 2024
While Rockland Trust saw deposit and net interest margin growth, a $54.6 million office loan was reclassified as non-performing executives said Friday morning, hampering the gains the bank made in the third quarter.
by Steve Adams | Sep 23, 2024
Three years after paying $210 million for an office building in Boston’s Leather District, a life science developer is proposing a partial conversion for lab space.
by Steve Adams | Sep 9, 2024
Owners of a successful office-to-life science conversion in Bedford received $150 million in refinancing for the 288,000-square-foot complex from Apollo Global Management.
by Steve Adams | Jan 11, 2024
Four life science companies have inked leases in a lab conversion of Andover Technology Park, including the new U.S. headquarters of a Bill & Melinda Gates Foundation-backed vaccine manufacturer.
by Steve Adams | Dec 12, 2023
A Finland-based environmental equipment company will relocate its local offices from Woburn to a lab conversion led by Jumbo Capital in Burlington.
by Steve Adams | Oct 22, 2023
Developers delivered the core and shell of a 288,000-square-foot lab and research building following the renovation and conversion of office space in a Bedford business park.
by Steve Adams | Jun 16, 2023
The largest community benefits agreement to support arts and culture in Boston history is the price that a lab developer will pay to replace Brighton’s Sound Museum with a life science campus.
by Steve Adams | Apr 25, 2023
Alexandria Real Estate Equities has dropped a planned 510,000-square-foot life science conversion in Newton, and recorded a $139-million impairment charge on the property.
by Steve Adams | Feb 19, 2023
Kerrie Julian has enjoyed an up-close perspective on Greater Boston’s powerful life science expansion over the past two decades. Now, as director of life science strategy at Margulies Perruzzi, she’s got a perfect perch to watch a sector in transition.
by Steve Adams | Jan 25, 2023
Life science space is the preferred future for a 10-story Downtown Crossing office building acquired in 2022 for $107 million.
by Steve Adams | Jan 18, 2023
A recent office-to-lab conversion by Jumbo Capital in Waltham received commitments from four new tenants totaling nearly 50,000 square feet.
by Steve Adams | Nov 18, 2022
The Boston Planning & Development Agency approved 1.6 million square feet of projects, including a pair of hotels and new lab buildings in the Leather District, Fort Point and the marine park.
by Steve Adams | Oct 19, 2022
The conversion of a former Liberty Mutual office property in Weston into a three-building life science campus received $150 million in construction financing.
by Steve Adams | Oct 4, 2022
The new owners of a Burlington office building received $87 million to convert the property into 175,000 square feet of life science space.
by Steve Adams | Sep 21, 2022
A Lexington diabetes research firm has signed the first lease at at a Burlington office building being converted into life science space.
by Steve Adams | Sep 16, 2022
Boston Planning & Development Agency directors approved over 480,000 square feet of real estate projects Thursday, while putting the brakes on a proposed lab conversion in Fort Point.
by Steve Adams | Sep 13, 2022
As it pivots from office to suburban life science projects, Boston Properties is proposing a redevelopment of a Lexington office park to create 425,450 square feet of office and lab space.
by Steve Adams | Apr 7, 2022
The new owners of a Westwood office building are set to begin a lab conversion that would become available to life science tenants in 2023.
by Steve Adams | Mar 29, 2022
A high-visibility Downtown Crossing office building could become one of Boston’s next lab conversions following a $107-million acquisition.
by Steve Adams | Feb 11, 2022
An office building across from Boston’s South Station will become life science research space after a developer confirmed no high-risk infectious disease research will be conducted.